MedDataX Logo

Image Data Collection Using a Multi-spectral Camera for Computer Vision Algorithms Research and Development

NCT ID: NCT05674149

Last Updated: 2023-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-21

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational, single-center, open-label photography evaluation. Any patient that arrives for consultation or treatment at the clinic, presenting the required lesions detailed in the protocol can be included.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational, single-center, open-label photography evaluation. Any patient that arrives for consultation or treatment at the clinic, presenting the required lesions detailed in the protocol can be included.

The specified lesions can be located on any area of the face or body. For consenting subjects at least 5 close-up images of at least one lesion and one reference image (e.g., subject's skin without any lesion) will be obtained using the Multi-spectral SMART camera. An additional reference image of the lesion area will be taken with a regular camera. Optional images may be taken using a dermatoscop

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vascular Lesion Pigmented Lesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multi-Spectral Camera

Multi-Spectral Camera will be used in order to capture images of different skin conditions

Group Type OTHER

camera

Intervention Type DEVICE

photographs using multi-spectral camera

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

camera

photographs using multi-spectral camera

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Any patient, male or female of at least 18 years old, who is willing to sign an informed consent form and present at least one of the following conditions:

1. Photoaging (type I - III per Glogau classification)- mixed conditions
2. Epidermal pigmentation / Lentigines (age spots, sun spots)
3. Facial rosacea (Erythematotelangiectatic rosacea and papulopustular rosacea)
4. Facial telangiectasia
5. Poikiloderma
6. Seborrheic keratosis
7. Melasma (Chloasma)

Exclusion Criteria

Any of the following will exclude the subject from the study:
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emek Medical Center

OTHER

Sponsor Role collaborator

Lumenis Be Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ha'Emek Medical Center

Afula, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rula Masoud, PhD

Role: CONTACT

Phone: 0503018155

Email: [email protected]

Michael Ziv, MD

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rula Masoud

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LUM-ABU-SMRT-22-04

Identifier Type: -

Identifier Source: org_study_id